Publication | Closed Access

Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations

Insertion MutationsBone Morphogenic ProteinMolecular BiologyEgfr Exon 20Preclinical ModelingSystems BiologyDrug Discovery